The Cigna Group (CI) Stock Analysis
Healthcare · Healthcare Plans · NYSE
The Cigna Group (CI) posted $274.90B in revenue for fiscal 2025 (up 11.3% year over year), at a 2.2% net margin, and has compounded revenue about 11.4%/yr over five years, per its SEC filings.
Data last refreshed August 2, 2026 from SEC filings · how we compute this
The analyst's take on The Cigna Group
The Cigna Group has grown revenue from $39.84B to $274.90B over the last 10 fiscal years, compounding about 11.4% a year. The most recent year was up 11.3%, roughly in line with its longer-run pace.
Net margin sits at 2.2%, up 0.8 points year over year on a 21.8% gross margin. It carries about $592.00M of total debt.
At today's valuation the market is pricing in roughly -3.8% annual free-cash-flow growth.
Synthesised from The Cigna Group's SEC filings — descriptive, not advice. Ask the analyst your own question →
The Cigna Group revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $39.84B | $41.81B | $48.65B | $153.57B | $160.40B | $174.07B | $180.64B | $195.32B | $247.10B | $274.90B |
| Gross profit | $37.37B | $39.35B | $43.86B | $55.90B | $56.92B | $56.52B | $55.81B | $61.52B | $64.59B | $59.91B |
| Net income | $1.84B | $2.23B | $2.65B | $5.12B | $8.49B | $5.42B | $6.67B | $5.16B | $3.43B | $5.96B |
| Net margin | 4.6% | 5.3% | 5.4% | 3.3% | 5.3% | 3.1% | 3.7% | 2.6% | 1.4% | 2.2% |
Source: The Cigna Group SEC filings (10-K).
The Cigna Group: no obvious red flags in the filings
Our deterministic scan of the filed statements — receivables vs sales, earnings vs cash, dilution, leverage and margins — didn't flag anything. Ask about the risks →
What growth is priced into CI stock?
At today's market cap of $73.74B, The Cigna Group is priced for free-cash-flow growth of about -3.8% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $8.44B from the FY ending 2019-12-31). For comparison, revenue 11.4%/yr, computed from its SEC filings. This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 10 years of The Cigna Group financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeThe Cigna Group financial history by metric
Compare The Cigna Group with peers
About The Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
The Cigna Group — frequently asked questions
What is The Cigna Group's revenue?
The Cigna Group (CI) reported revenue of $274.90B for fiscal year 2025, up 11.3% from the prior year, according to its SEC filings.
Is The Cigna Group profitable?
Yes. CI earned net income of $5.96B in fiscal 2025, a net margin of 2.2%.
What is CI's P/E ratio?
The Cigna Group trades at a price-to-earnings ratio of about 11.5 based on the latest data in our nightly-refreshed cache.
How fast is The Cigna Group growing?
CI's revenue grew at roughly 11.4% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does The Cigna Group have?
As of fiscal year 2025, CI carried roughly $592.00M in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is The Cigna Group's gross margin?
CI's gross margin was 21.8% in fiscal 2025 — gross profit of $59.91B on revenue of $274.90B.
What is The Cigna Group's market cap?
The Cigna Group (CI) has a market capitalization of about $73.74B, based on the latest data in our nightly-refreshed cache.
When does The Cigna Group's fiscal year end?
CI's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
What growth is priced into CI stock?
At today's market cap of $73.74B, The Cigna Group is priced for free-cash-flow growth of about -3.8% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $8.44B from the FY ending 2019-12-31). For comparison, revenue 11.4%/yr, computed from its SEC filings.
Where does this data come from?
All figures are computed from The Cigna Group's official SEC filings (10-K and 10-Q), covering 10 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.